Similar Articles |
|
Pharmaceutical Executive June 1, 2012 |
A Brand Positioning Nightmare New drug indications can be a brand manager's worst nightmare or a dream come true. The difference lies in the perspective and in the branding strategy. |
Nursing July 2011 Susan Simmons |
Recognizing and Managing Rheumatoid Arthritis Here's what rheumatoid arthritis is, how it's diagnosed and treated, and what you can do to help patients manage the disease. |
Pharmaceutical Executive July 30, 2007 Stewart Young |
Marketing to Professionals: The Essence of a Brand Beyond good messaging, marketers must establish a brand that is forever etched into physicians' minds. |
Pharmaceutical Executive June 1, 2011 Andrew Matthews et al. |
Managing Product Lifecycle Patent expiries are inevitable, but brand teams should look to graduate the sales curve. |
Pharmaceutical Executive May 1, 2009 Maryann Kuzel |
Weathering the Storm Marketers must stress that maintaining good health behaviors is one of the best things people can do to survive a down market. |
Pharmaceutical Executive July 1, 2005 Ken Dec |
Direct to Consumer: Moving House The "House of Brands" model is a house of cards. The pharmaceutical industry should change, or risk losing trust forever. |
Pharmaceutical Executive May 1, 2012 |
Best Practices: Commercial Analytics If the relationship between marketers and commercial analytics in the pharmaceutical and biotech sectors is leveraged properly, it can help marketers make more informed strategic decisions for their brands. |
Nursing June 2011 Daniel A. Hussar |
New Drugs 2011: Part 2 In this article, you'll learn about seven recently approved drugs, including: fingolimod hydrochloride, an oral drug indicated to treat patients with relapsing forms of multiple sclerosis. |
CRM May 23, 2013 Maria Minsker |
Branded Content Marketing Sees Increase in Importance More than 70 percent of brands and agencies surveyed plan to spend more on it next year. |
Pharmaceutical Executive June 1, 2012 Amy Smith |
Marketing: Medical Devices vs. Pharma Understanding the differences between drug and device marketing can make or break the brand's promotional activities. |
Pharmaceutical Executive July 1, 2009 Stan Bernard |
Forget Brand vs. Brand--This is War Increasingly, pharma companies are expanding from brand vs. brand to battle at the franchise, portfolio, and corporate levels. |
CRM January 13, 2012 Rich Flek |
Harnessing the Power of Social Media Are you prepared to meet the challenge? |
Fast Company |
Watch 128 years Of Coca-Cola's History In 2 Minutes We look at the pivotal moments in the history of one of the world's most instantly recognizable, and valuable, brands. |
Pharmaceutical Executive January 1, 2006 Gina Ashe |
Alternative Media: Patient Bloggers on Your Brands Find out what patient bloggers are saying about your pharmaceutical brands. |
Nursing February 2010 Daniel A. Hussar |
New Drugs 2010, PART 1 In this article, you'll learn about 16 new drugs. |
Nurse Practitioner June 2011 Eva Hardy |
Gout Diagnosis and Management: What NPs Need to Know Because primary care providers diagnose and treat the vast majority of patients with gout, it is important that they understand current guidelines and evidence-based practice. |
Fast Company February 2002 Scott Bedbury |
Nine Ways to Fix a Broken Brand The marketing excesses of the past few years left broken pieces scattered across the branding landscape. As a result, many companies are left with bogged-down, boring -- even dying and dead -- brands. Now take a look at your brand: Do you know what's broken? Do you know how to fix it? |
The Motley Fool January 12, 2012 Isaac Pino |
How American Brands Rule the World The best global brands can provide a boost to your portfolio. |
Pharmaceutical Executive December 1, 2012 |
Big Data, Bigger Ideas How to stop worrying and learn to love the data. Let's face it and let's be brave about it: the balance of power has shifted permanently from the marketers to the marketed. |
The Motley Fool February 28, 2011 Brian Orelli |
Look Out for Big Growth From This Drug Regeneron's ultra-orphan drug Arcalyst takes a step forward toward a wider audience. |
CIO October 29, 2015 Martha Heller |
Amgen uses algorithms to venture into digital healthcare A senior vice president of global marketing and commercial development, says she's working with the CIO to set up a digital healthcare organization that can help physicians better predict how patients will respond to therapies. |
CRM May 2015 Leonard Klie |
The Customer Expectation -- Experience Gap Brand Keys' Customer Loyalty Engagement Index finds that many companies are unable to deliver on emotional values. |
The Motley Fool March 9, 2010 Brian Orelli |
The Opportunity That Wasn't Roche and Biogen Idec are suspending development of ocrelizumab for rheumatoid arthritis because patients are coming down with opportunistic infections. |
Food Processing July 2011 Diane Toops |
Food Processors Find Public Growth for Private Label The price differential between branded food and store brands is still there, augmented by higher quality and healthier formulations. |
HBS Working Knowledge May 31, 2004 Manda Salls |
The Strategic Role of Marketing In the book Marketing as Strategy, London Business School's Nirmalya Kumar argues that marketing must help drive organizational change. |
Fast Company September 2000 Alan M. Webber |
Trust in the Future When it comes to brand management, Kevin Roberts says that only two things are wrong: brands and management. |
Pharmaceutical Executive November 1, 2014 Mark Perlotto |
Digital's Place in the Pharma Marketing Mix The rush to digital will continue at a fast clip, but marketers need to reacquaint themselves with their brands' audiences. |
CRM January 2014 Sarah Sluis |
Social Media Leads Content Marketing Quickly digested forms of content distribution win out over in-depth methods. |
Wired November 2004 James Surowiecki |
The Decline of Brands There's something strange going on in branding land. Even as companies have spent enormous amounts of time and energy introducing new brands and defending established ones, Americans have become less loyal. |
Managed Care November 2005 Vogenberg, Liebeskind & Ritter |
Addressing the Hidden Costs of Rheumatoid Arthritis Health plans can work directly with customers to design rheumatoid arthritis management plans that address indirect but substantial costs. |
BusinessWeek August 4, 2003 Gerry Khermouch |
America Has Image Woes, Not Its Brands Despite foreign fears of the country's go-it-alone attitude, the impact on its iconic product names has been negligible. |
CRM December 14, 2012 Mark Cooper |
The Rise of the Agile Consumer Traditional CRM systems are failing to keep pace with today's customer. |
Fast Company Bankarim & Heiselman |
How Do I Brand My Business to Stand Out From The Competition? Just because you love your business doesn't mean it's always easy to tell your company's story to the world. Good branding is part art, part science. |
CRM October 7, 2011 Tim Suther |
Personalize Content by Knowing Your Audience Here are a few tips that marketers should use when they seek to deliver the best possible personalized content when reaching out to their target audience. |
CRM November 2014 Maria Minsker |
How to Create the Right Content for the Right Social Channel Marketers should understand and leverage the unique qualities of each network to drive conversations and conversion. |
HBS Working Knowledge September 20, 2004 Holt, Quelch, & Taylor |
How Consumers Value Global Brands What do consumers expect of global brands? Does it hurt to be an American brand? This Harvard Business Review excerpt identifies the three characteristics consumers look for to make purchase decisions. |
Food Processing August 2012 Diane Toops |
The Private World of Private Label Food Brands Will the category's 'quality copy-cat' reputation hold up after the recession? |
Pharmaceutical Executive December 1, 2005 Meg Columbia-Walsh |
Direct to Consumer: Culturally Relevant Marketing Through culturally relevant marketing, pharma can seamlessly weave its brands into consumers' lives... Also: The 2005 Pharmaceutical Advertising and Marketing Excellence Award recipients... |
HBS Working Knowledge April 26, 2010 Sarah Jane Gilbert |
When Other Companies Compete Like Crazy, Dare to Be Different As Harvard Business School professor Youngme Moon argues in Different: Escaping the Competitive Herd, competition too often breeds conformity. |
HBS Working Knowledge February 5, 2009 John Quelch |
In Praise of Marketing Marketers do a surprisingly poor job of marketing the importance of marketing. Here is the story that needs to be told. |